ArticleOpen forum infectious diseases2022

Evaluating Diversity in Randomized Clinical Trials of Dolutegravir-Based Antiretroviral Therapy Regimens: Pooled 48-Week Analyses by Race, Sex, and Regional Subgroups.

M Keith Rawlings et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.